Peripheral blood T-cell populations in COPD, asymptomatic smokers and healthy non-smokers in Indian subpopulation-a pilot study

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 6, 2013, Pages 1109-1113

  Rashmi Teresa Mathai, K ^a   Bhat, Smitha ^a  

^a FATHER MULLER MEDICAL COLLEGE   (India)

Author keywords

Autoimmune; Chronic obstructive pulmonary disease; Peripheral blood T cells; Smokers

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; INDIAN; LYMPHOCYTE COUNT; MALE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PILOT STUDY; POPULATION RESEARCH; SMOKING; SPIROMETRY; T LYMPHOCYTE SUBPOPULATION;

EID: 84878530299     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5977.3094     Document Type: Article

References (15)

1. Barnes PJ. Chronic Obstructive Pulmonary Disease. N Engl J Med. 2000;343:269-80.
2. Sabroe I, Parker LC, Calverley PM, et al. Pathological networking: A new approach to understanding COPD. Postgrad Med J. 2008;84:259-64.
3. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:711-7.
4. Kim WD, Kim WS, Koh Y, et al. Abnormal peripheral blood T-lym-phocyte subsets in a subgroup of patients with COPD. Chest. 2002;122:437-44.
5. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur Respir J. 2001;17:946-53.
6. De Jong JW, Gritter B, Koeter GH, et al. Peripheral blood lympho-cyte cell subsets in subjects with chronic obstructive pulmonary dis-ease: association with smoking, IgE and lung function. Respir Med. 1997;91:67-76.
7. Miller LG, Goldstein G, Murphy M, et al. Reversible alterations in im-munoregulatory T-cells in smoking: analysis by monoclonal antibod-ies and flow cytometry. Chest. 1982;5:526-9.
8. Koch A, Gaczkowski M, Sturton G, et al. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Eur Respir J. 2007; 29:42-50.
9. Pons J, Sauleda J, Ferrer JM, et al. Blunted γδ T lymphocyte re-sponse in chronic obstructive pulmonary disease. Eur Respir J. 2005; 25:441-6.
10. Gadgil A, Zhu X, Sciurba FC, Duncan SR. Altered T-cell phenotypes in COPD. Proc Am Thorac Soc. 2006; 3.
11. Hodge SJ, Hodge GL, Reynolds PN, Scicchitano R, Holmes M. In-creased production of TGF-b and apoptosis of T lymphocytes iso-lated from peripheral blood in COPD. Am J Physiol Lung Cell Mol Physiol. 2003;285:L492-L99.
12. Majori M, Corradi M, Caminati A, Cacciani G, Bertacco S, Pesci A. Predominant Th1 cytokine pattern in perpheral blood from subjects with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1999;103:458-62.
13. Glader P, Wachenfeldt K, Lofdahl CG. Systemic CD4+ T-cell acti-vation is correlated with FEV1 in smokers. Respir Med. 2006;100; 1088-93.
14. Zhu X, Gadgil AS, Givelber R, George MP. Peripheral T-cell functions correlate with the severity of COPD. J Immunol. 2009;182;3270-7.
15. Shirai T, Suda T, Inui N, Chida K. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in sta-ble COPD. Allergol Int. 2010;59:75-82.